Nasdaq:US$14.80 (-0.05) | HKEX:HK$22.90 (-0.30) | AIM:£2.24 (-0.06)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 6 Apr 2013

AACR 2013: Preclinical disposition and pharmacokinetics of savolitinib, a novel selective cMet inhibitor